Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia

References

• [accessed 2020 May 5]. https://data.worldbank.org/country/uzbekistan
   Google Scholar
• Tate JE, Burton AH, Boschi P, Parashar UD. WHO-coordinated global rotavirus surveillance network. global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;S2:S96–S105.
   Google Scholar
• Ahmedov M, Azimov R, Mutalova Z, Huseynov S, Tsoyi E, Rechel B. Uzbekistan: health system review. Health Syst Transit. 2014;16:1–137.
   PubMedGoogle Scholar
• [accessed 2020 May 5]. https://www.who.int/immunization/monitoring_surveillance/data/uzb.pdf
   Google Scholar
• Latipov R, Utegenova E, Kuatbayeva A, Kasymbekova K, Abdykarimov S, Juraev R, Ismailov U, Flem E. Epidemiology and burden of rotavirus disease in Central Asia. Int J Infect Dis. 2011 Jul;15(7):e464–9. doi:10.1016/j.ijid.2011.03.014.
   PubMed Web of Science ®Google Scholar
• Flem ET, Musabaev E, Juraev R, Kerin T, Gentsch J, Glass RI, Bresee JS. Rotavirus gastroenteritis in Uzbekistan: implications for vaccine policy in central Asia. J Infect Dis. 2009 Nov 1;200(Suppl 1):S154–9. doi:10.1086/605032.
   PubMedGoogle Scholar
• Isakbaeva ET, Musabaev E, Antil L, Rheingans R, Juraev R, Glass RI, Bresee JS. Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine. 2007 Jan 4;25(2):373–80. doi:10.1016/j.vaccine.2006.07.029.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Generic protocol for monitoring impact of rotavirus vaccination on rotavirus disease burden and viral strains. WHO, 2009 cited 2019 Dec 17. Available from: https://www.who.int/immunization/monitoring_surveillance/resources/NUVI/en/
   Google Scholar
• Bowen MD, Mijatovic-Rustempasic S, Esona MD, Teel EN, Gautam R, Sturgeon M, Azimi PH, Baker CJ, Bernstein DI, Boom JA et al. Rotavirus strain trends during the postlicensure vaccine Era: united States, 2008–2013. J Infect Dis. 2016 Sep 1;214(5):732–38. doi:10.1093/infdis/jiw233.
   PubMed Web of Science ®Google Scholar
• Esona MD, Gautam R. Rotavirus. Clin Lab Med. 2015 Jun;35(2):363–91. doi:10.1016/j.cll.2015.02.012.
   PubMed Web of Science ®Google Scholar
• Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006–2016. Clin Infect Dis. 2017 Sep 1;65(5):840–50. doi:10.1093/cid/cix369.
   PubMed Web of Science ®Google Scholar
• Sahakyan G, Grigoryan S, Wasley A, Mosina L, Sargsyan S, Asoyan A, Gevorgyan Z, Kocharyan K, Avagyan T, Lopman B et al. Impact and effectiveness of monovalent rotavirus vaccine in Armenian CHILDREN. Clin Infect Dis. 2016 May 1;62(Suppl 2):S147–54. doi:10.1093/cid/ciw045.
   PubMed Web of Science ®Google Scholar
• Gheorghita S, Birca L, Donos A, Wasley A, Birca I, Cojocaru R, Melnick A, Ciobanu S, Mosina L, Cortese MM, et al. Impact of rotavirus vaccine introduction and vaccine effectiveness in the Republic of Moldova. Clin Infect Dis. 2016 May 1;62(Suppl 2):S140–6. doi:10.1093/cid/civ1209.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007 Nov 24;370(9601):1757–63. doi:10.1016/S0140-6736(07)61744-9.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006 Jan 5;354(1):23–33. PubMed PMID: 16394299. doi:10.1056/NEJMoa052664.
   PubMed Web of Science ®Google Scholar
• Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, Fahmy K, Teleb N, Ashmony HA, Ahmed H, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under5 years of age, 2008–16: findings from the Global Rotavirus Surveillance Network. Lancet Glob Health. 2019 Jul;7(7):e893–e903. doi:10.1016/S2214-109X(19)30207-4.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006 Jan 5;354(1):11–22. doi:10.1056/NEJMoa052434.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis. 2015;15:422–28. doi:10.1016/S1473-3099(14)71060-6.
   PubMed Web of Science ®Google Scholar
• Leshem E, Lopman B, Glass R, Gentsch J, Bányai K, Parashar U, Patel M. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 2014 Sep;14(9):847–56. doi:10.1016/S1473-3099(14)70832-1.
   PubMed Web of Science ®Google Scholar
• Pitzer VE, Bilcke J, Heylen E, Crawford FW, Callens M, De Smet F, Van Ranst M, Zeller M, Did Large-Scale MJ. Vaccination drive changes in the circulating rotavirus population in Belgium? Sci Rep. 2015 Dec 21;5:18585. doi:10.1038/srep18585.
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Zeller M, Heylen E, De Coster S, Vercauteren J, Braeckman T, Van Herck K, Meyer N, PirÇon J-Y, Soriano-Gabarro M, et al. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. Clin Microbiol Infect. 2014 Oct;20(10):0702–10. doi:10.1111/1469-0691.12612.
   Web of Science ®Google Scholar
• Roczo-Farkas S, Kirkwood CD, Cowley D, Barnes GL, Bishop RF, Bogdanovic-Sakran N, Boniface K, Donato CM, Bines JE. The impact of rotavirus vaccines on genotype diversity: A comprehensive analysis of 2 decades of Australian surveillance data. J Infect Dis. 2018 Jul 13;218(4):546–54. doi:10.1093/infdis/jiy197.
   PubMed Web of Science ®Google Scholar